Companies: 10,795·Total market cap: $144.5T
Gritstone bio, Inc.

Gritstone bio, Inc.

GRTSNASDAQHealthcare
$0.03
$-0.02(-31.78%)
Market Cap$3803110
P/E Ratio
52W High$3.17
52W Low$0.03
Overview

Gritstone bio, Inc.(GRTS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · GRTS · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2023-122022-122021-122020-122019-12
Revenue
Revenue$1.33M$9.27M$46.72M$4.04M$4.37M
Cost of Revenue$7.59M$15.69M$14.40M$88.64M$82.90M
Gross Profit($6.26M)($6.42M)$32.32M($84.61M)($78.53M)
Gross Margin %(computed)-470.32%-69.28%69.18%
Operating Expenses
R&D Expenses$127.18M$111.40M$97.49M$88.64M$82.90M
G&A Expenses$28.78M$28.97M$25.93M$21.41M$19.41M
Total Operating Expenses$148.37M$129.70M$121.93M$110.05M$102.31M
Operating Income($154.63M)($120.43M)($75.21M)($106.02M)($97.94M)
Operating Margin %(computed)-160.99%
Interest Income$5.20M$1.98M$0.16M$0.71M$3.51M
Interest Expense$4.04M$1.24M$0.04M$0.01M$0.00M
Income Before Tax($138.49M)($119.69M)($75.08M)($105.31M)($94.43M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($138.49M)($113.13M)($74.95M)($104.61M)($90.93M)
Net Margin %(computed)-160.44%
Per Share & EBITDA
EPS (Basic)$-1.20$-1.24$-0.95$-2.77$-2.71
Wtd Avg Shares115.53M90.92M78.89M37.79M33.55M
EBITDA($126.86M)($111.89M)($68.70M)($98.67M)($93.19M)
EBITDA Margin %(computed)-147.05%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Gritstone bio, Inc.

关于Gritstone bio, Inc.(GRTS)损益表

Gritstone bio, Inc.(GRTS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2023财年,GRTS实现营收$0.00B,毛利润($0.01B)(毛利率-470.32%),净利润($0.14B)(净利率-10404.96%)。

常见问题

GRTS · 4 问

Gritstone bio, Inc.(GRTS)2023财年营收为$0.00B,同比down85.6%。

GRTS revenueGRTS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09